China-based 3D printing pharma startup secures funding worth $50 M

Retrieved on: 2021-06-24 11:37:30

Tags for this article:

Health sciences

Articles

Health care

Emerging technologies

Industrial design

Industrial processes

Pharmaceutical industry in China

Pharmaceuticals policy

Pharmacy in China

3D printing

Pharmaceutical industry

Triastek Inc.

Matrix Partners China

Click the tags to see associated articles and topics

China-based 3D printing pharma startup secures funding worth $50 M. View article details on HISWAI: https://www.biospectrumasia.com/news/25/18445/china-based-3d-printing-pharma-startup-secures-funding-worth-50-m.html

Excerpt

This round of investment was co-led by Matrix Partners China and CPE, with participation from Shanghai Sci-Tech Innovation Center Capital (SSICC) ...

Article found on: www.biospectrumasia.com

View Original Article